These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25697685)

  • 21. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
    Arora U; Tyagi P; Swaminathan S; Khanna N
    Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice.
    Izquierdo A; García A; Lazo L; Gil L; Marcos E; Alvarez M; Valdés I; Hermida L; Guillén G; Guzmán MG
    Arch Virol; 2014 Oct; 159(10):2597-604. PubMed ID: 24841761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Panbio dengue virus nonstructural 1 antigen detection and immunoglobulin M antibody enzyme-linked immunosorbent assays for the diagnosis of acute dengue infections in Laos.
    Blacksell SD; Mammen MP; Thongpaseuth S; Gibbons RV; Jarman RG; Jenjaroen K; Nisalak A; Phetsouvanh R; Newton PN; Day NP
    Diagn Microbiol Infect Dis; 2008 Jan; 60(1):43-9. PubMed ID: 17889487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of a recombinant dengue-2 virus-dengue-3 virus hybrid envelope protein expressed in a secretory baculovirus system.
    Bielefeldt-Ohmann H; Beasley DW; Fitzpatrick DR; Aaskov JG
    J Gen Virol; 1997 Nov; 78 ( Pt 11)():2723-33. PubMed ID: 9367357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes.
    Etemad B; Batra G; Raut R; Dahiya S; Khanam S; Swaminathan S; Khanna N
    Am J Trop Med Hyg; 2008 Sep; 79(3):353-63. PubMed ID: 18784226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of dengue virus.
    Tripathi NK; Shrivastava A; Dash PK; Jana AM
    Methods Mol Biol; 2011; 665():51-64. PubMed ID: 21116795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and characterization of an M cell-specific ligand-fused dengue virus tetravalent epitope using Saccharomyces cerevisiae.
    Nguyen NL; So KK; Kim JM; Kim SH; Jang YS; Yang MS; Kim DH
    J Biosci Bioeng; 2015 Jan; 119(1):19-27. PubMed ID: 25027708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and evaluation of baculovirus-expressed Chikungunya virus E1 envelope proteins for serodiagnosis of Chikungunya infection.
    Kumar P; Pok KY; Tan LK; Angela C; Leo YS; Ng LC
    J Virol Methods; 2014 Sep; 206():67-75. PubMed ID: 24880071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant polypeptide antigen-based immunoglobulin G enzyme-linked immunosorbent assay for serodiagnosis of dengue.
    Dos Santos FB; Nogueira RM; Lima MR; De Simone TS; Schatzmayr HG; Lemes EM; Harris E; Miagostovich MP
    Clin Vaccine Immunol; 2007 May; 14(5):641-3. PubMed ID: 17392435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant envelope protein-based enzyme immunoassay for IgG antibodies is comparable to neutralization tests for epidemiological studies of dengue infection.
    Rocha ES; Oliveira JG; Santos JR; Rodrigues GO; Figueiredo LB; Pessanha JE; Proietti FA; Fonseca FG; Bonjardim CA; Ferreira PC; Kroon EG
    J Virol Methods; 2013 Jan; 187(1):114-20. PubMed ID: 23018061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated process for the purification and immobilization of the envelope protein domain III of dengue virus type 2 expressed in Rachiplusia nu larvae and its potential application in a diagnostic assay.
    Smith ME; Targovnik AM; Cerezo J; Morales MA; Miranda MV; Talou JR
    Protein Expr Purif; 2017 Mar; 131():76-84. PubMed ID: 27888023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of IgM specific recombinant dengue multiepitope protein for early diagnosis of dengue infection.
    Tripathi NK; Shrivastva A; Pattnaik P; Parida M; Dash PK; Gupta N; Jana AM; Rao PV
    Biotechnol Prog; 2007; 23(2):488-93. PubMed ID: 17256968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A custom-designed recombinant multiepitope protein as a dengue diagnostic reagent.
    AnandaRao R; Swaminathan S; Fernando S; Jana AM; Khanna N
    Protein Expr Purif; 2005 May; 41(1):136-47. PubMed ID: 15802231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Performance of Dengue Virus Envelope Domain III in Acute Dengue Infection.
    Nguyen NM; Duong BT; Azam M; Phuong TT; Park H; Thuy PTB; Yeo SJ
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of rapid immunochromatographic NS1 test, anti-dengue IgM test, semi-nested PCR and IgM ELISA for detection of dengue virus.
    Tontulawat P; Pongsiri P; Thongmee C; Theamboonlers A; Kamolvarin N; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):570-8. PubMed ID: 21706935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dengue Virus IgM Serotyping by ELISA with Recombinant Mutant Envelope Proteins.
    Rockstroh A; Barzon L; Kumbukgolla W; Su HX; Lizarazo E; Vincenti-Gonzalez MF; Tami A; Ornelas AMM; Aguiar RS; Cadar D; Schmidt-Chanasit J; Ulbert S
    Emerg Infect Dis; 2019 Jan; 25(1):1111-1115. PubMed ID: 30387417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of dengue NS1 antigen for early diagnosis of dengue virus infection.
    Kassim FM; Izati MN; TgRogayah TA; Apandi YM; Saat Z
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):562-9. PubMed ID: 21706934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early diagnosis of dengue in travelers: comparison of a novel real-time RT-PCR, NS1 antigen detection and serology.
    Huhtamo E; Hasu E; Uzcátegui NY; Erra E; Nikkari S; Kantele A; Vapalahti O; Piiparinen H
    J Clin Virol; 2010 Jan; 47(1):49-53. PubMed ID: 19963435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections.
    Holmes DA; Purdy DE; Chao DY; Noga AJ; Chang GJ
    J Clin Microbiol; 2005 Jul; 43(7):3227-36. PubMed ID: 16000440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of tetravalent and conserved synthetic peptides vaccines derived from Dengue virus Envelope domain I and II.
    Rocha RP; Livonesi MC; Fumagalli MJ; Rodrigues NF; da Costa LC; Dos Santos MC; de Oliveira Rocha ES; Kroon EG; Malaquias LC; Coelho LF
    Virus Res; 2014 Aug; 188():122-7. PubMed ID: 24768848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.